Robotic hysterectomy - Protocol for a health technology assessment
The national system for managed introduction of new health technologies has commissioned the Norwegian institute of public health to conduct a health technology assessment (HTA) on robot-assisted hysterectomy.
About the project
-
Project period: 29.03.2023 - 28.03.2024 (Active)
- Coordinating Institution: Norwegian Institute of Public Health
-
Project Manager:
- Christine Hillestad Hestevik, Norwegian Institute of Public Health
-
Project Participants:
- Jon-Vidar Gaustad, Norwegian Institute of Public Health
- Gunhild Hagen, Norwegian Institute of Public Health
- Ingrid Harboe, Norwegian Institute of Public Health
- Vida Hamidi Ashtiani, Norwegian Institute of Public Health
- Hilde Risstad, Norwegian Institute of Public Health
- Project plan: Godkjent prosjektplan robotassistert hysterektomi.pdf
Summary
The use of robot-assisted surgery in hysterectomy is increasing for malignant and benign diagnoses. Despite this, the clinical effect and cost-effectiveness of robot-assisted hysterectomy have not been compared with other surgical techniques for hysterectomy in a Norwegian context
The regional health authorities (RHF’s) have identified a need for a strategic approach for introduction and use of robotic surgery in Norway. The national system for managed introduction of new health technologies has commissioned the Norwegian institute of public health to conduct a health technology assessment (HTA) on robot-assisted hysterectomy.
In this HTA, we will summarize the knowledge on robot-assisted hysterectomy for benign indications and endometrial cancer. The method will be compared with open, vaginal and conventional laparoscopic hysterectomy.
We will perform a systematic literature search in relevant databases and assess identified publications against the inclusion criteria. We will evaluate the methodological quality of the included studies and compile the results in meta-analysis when considered appropriate. Our confidence in the results, including transferability to the Norwegian context, will also be assessed. A health economic analysis will evaluate the method considering the agreed priority criteria. The work will be performed in collaboration with clinical experts from different RHF’s as well as user representatives.